CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.
View Top Employees from CRISPR TherapeuticsWebsite | http://www.crisprtx.com |
Ticker | CRSP |
Revenue | $289 million |
Funding | $56 million |
Employees | 539 (539 on RocketReach) |
Founded | 2013 |
Address | 105 West First Street, Boston, Massachusetts 02127, US |
Phone | +41 41 561 32 77 |
Technologies |
JavaScript,
HTML,
Twitter
+64 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biopharma, Healthcare, Biotechnology, Health Care, Science and Engineering, Genetics, Medical |
Web Rank | 1 Million |
Keywords | Gene Editing, Therapeutic Activities, Oncology, Regenerative Agriculture, Rare Disease |
Competitors | Anthera Pharmaceuticals, Applied StemCell, Editas Medicine, Intellia Therapeutics, Inc., Sage Therapeutics |
SIC | SIC Code 87 Companies, SIC Code 37 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 33 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies |
Looking for a particular CRISPR Therapeutics employee's phone or email?
The CRISPR Therapeutics annual revenue was $289 million in 2024.
Phuong Morrow is the Chief Medical Officer of CRISPR Therapeutics.
539 people are employed at CRISPR Therapeutics.
CRISPR Therapeutics is based in Boston, Massachusetts.
The NAICS codes for CRISPR Therapeutics are [541, 33, 54, 54171, 5417, 541711].
The SIC codes for CRISPR Therapeutics are [87, 37].